Equity Tips Free TrialIndian Share Market TipsIndian Stock Market TipsRipples AdvisoryStock cash TipsStock cash Tips High accuracyStock tipsStock Trading Tips
Indian Stock Market Tips -Tata Motors Or Lupin Top Update Today
Tata Motors gains with arm reporting 14,079 units US sales for December 2018
Tata Motors is currently trading at Rs. 177.65, up by 2.40 points or 1.37% from its previous closing of Rs. 175.25 on the BSE.
The scrip opened at Rs. 176.30 and has touched a high and low of Rs. 178.35 and Rs. 176.10 respectively. So far 170728 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 443.55 on 09-Jan-2018 and a 52 week low of Rs. 154.70 on 11-Dec-2018.
Last one week high and low of the scrip stood at Rs. 178.30 and Rs. 165.40 respectively. The current market cap of the company is Rs. 50600.79 crore.
The promoters holding in the company stood at 37.27%, while Institutions and Non-Institutions held 36.21% and 13.63% respectively.
Tata Motors’ wholly owned subsidiary -- Jaguar Land Rover (JLR) has reported 14,079 units US sales for the month of December 2018, a 24% increase from 11,394 units in December 2017. Land Rover reported its best-ever December sales month with 10,617 units, an increase of 33% from 7,980 in December 2017, while Jaguar sales were 3,462 units, a slight increase from 3,414 units in December 2017.
Tata Motors is India’s largest automobile company. Through subsidiaries and associate companies, Tata Motors has operations in the UK, South Korea, Thailand, South Africa, and Indonesia. Among them is Jaguar Land Rover, the business comprising the two iconic British brands.
Lupin gains on getting USFDA’s approval for Lurasidone Hydrochloride Tablets
Lupin is currently trading at Rs. 825.35, up by 4.45 points or 0.54% from its previous closing of Rs. 820.90 on the BSE.
The scrip opened at Rs. 829.80 and has touched a high and low of Rs. 829.80 and Rs. 815.00 respectively. So far 14935 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 986.00 on 10-Sep-2018 and a 52 week low of Rs. 723.55 on 15-May-2018.
Last one week high and low of the scrip stood at Rs. 847.35 and Rs. 815.00 respectively. The current market cap of the company is Rs. 37137.96 crore.
The promoters holding in the company stood at 47.00%, while Institutions and Non-Institutions held 37.69% and 15.30% respectively.
Lupin has received approval from the United States Food and Drug Administration (USFDA) for Lurasidone Hydrochloride Tablets, 20 mg, 40 mg, 60 mg, 80 mg & 120 mg to market a generic version of Sunovion Pharmaceuticals, Inc's Latuda Tablets, 20 mg, 40 mg, 60 mg, 80 mg, and 120 mg.
Lupin's Lurasidone Hydrochloride Tablets is indicated for the treatment of adult patients with schizophrenia, monotherapy treatment of adult patients with major depressive episode associated with bipolar I disorder and adjunctive treatment with lithium or valproate in adult patients with major depressive episode associated bipolar I disorder (bipolar depression).
Latuda Tablets, 20 mg, 40 mg, 60 mg, 80 mg, and 120 mg had annual sales of approximately $3217.3 million in the US (IQVIA MAT September 2018).
Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products, and APIs globally.
A Special Offer for a Special Season! Get Stock Cash Tips to start from 2 Days Free Trial Click Here- Stock Cash Tips "we provide secure, Smooth Deals You Can Trust"
0 comments
Note: only a member of this blog may post a comment.